SV Health Investors Team
Photo of Houman Ashrafian, Managing Partner at SV Health Investors
Houman Ashrafian
SV Health Investors·Managing Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in London
Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in London (Other Lists), Investors in BioTech (Series A), Investors in BioTech (Seed)
Photo of Alex Badamchi-Zadeh, Senior Associate at SV Health Investors
Alex Badamchi-Zadeh
SV Health Investors·Senior Associate
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in London
Investors in London (Other Lists), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed)
Photo of Josh Baker, Analyst at SV Health Investors
Josh Baker
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA)
Photo of Michael Balmuth, Managing Partner at SV Health Investors
Michael Balmuth
SV Health Investors·Managing Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA)
Photo of Laurence Barker, Partner at SV Health Investors
Laurence Barker
Sweet spot: $1.5M
Range: $100K - $1.5M
Investors in London
Investors in Pharmaceuticals (Series B), Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series B), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series B), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series B), Investors in London (Other Lists), Investors in BioTech (Series A), Investors in BioTech (Seed)
Photo of Jonathan Behr, Partner at SV Health Investors
Jonathan Behr
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Cambridge (MA)
Photo of Kate Bingham, Managing Partner at SV Health Investors
Kate Bingham
SV Health Investors·Managing Partner
Sweet spot: $1.5M
Range: $30K - $3.0M
Investors in London
Photo of Rebecca Canter, Associate at SV Health Investors
Rebecca Canter
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in United Kingdom
Investors in Pharmaceuticals (Series B), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series B), Investors in BioTech (Series A), Investors in BioTech (Seed)
Photo of Charles Dunn, Associate at SV Health Investors
Charles Dunn
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in United Kingdom, Investors in London
Investors in BioTech (Series B), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in London (Other Lists), Investors in BioTech (Series B), Investors in BioTech (Series A), Investors in BioTech (Seed)
Photo of Tom Flynn, Managing Partner at SV Health Investors
Tom Flynn
SV Health Investors·Managing Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA)
Photo of William Gerard, Analyst at SV Health Investors
William Gerard
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA)
EH
Eugene Hill
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston / New England, Investors in Boston (MA)
Photo of Christian Jung, Partner at SV Health Investors
Christian Jung
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in United Kingdom, Investors in London
Investors in BioTech (Series B), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in London (Other Lists), Investors in BioTech (Series B), Investors in BioTech (Series A), Investors in BioTech (Seed)
Photo of Jack Kenney, Associate at SV Health Investors
Jack Kenney
Sweet spot: $1.5M
Range: $30K - $3.0M
Investors in Europe, Investors in Israel, Investors in United Kingdom, Investors in United States
Photo of Dirk Landgraf, Senior Associate at SV Health Investors
Dirk Landgraf
SV Health Investors·Senior Associate
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA)
Photo of Paul LaViolette, Managing Partner at SV Health Investors
Paul LaViolette
SV Health Investors·Managing Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA)
Investors in Medical Devices (Series B), Investors in Medical Devices (Seed), Investors in Medical Devices (Series A), Investors in BioTech (Series B), Investors in Medical Devices (Series B), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Medical Devices (Series A), Investors in Medical Devices (Seed), Investors in BioTech (Series B), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Boston / New England (Other Lists)
Photo of Megan MacDonagh, Senior Associate at SV Health Investors
Megan MacDonagh
SV Health Investors·Senior Associate
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA)
Photo of Greg Madden, Managing Partner at SV Health Investors
Greg Madden
SV Health Investors·Managing Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA)
Photo of Niyoshi Patel, Associate at SV Health Investors
Niyoshi Patel
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA)
Photo of Marek Poszepczynski, Investor at SV Health Investors
Marek Poszepczynski
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Stockholm (Sweden)
Investors in Pharmaceuticals (Series B), Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series B), Investors in BioTech (Series A), Investors in BioTech (Seed)
Photo of Mike Ross, Managing Partner at SV Health Investors
Mike Ross
SV Health Investors·Managing Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in United States, Investors in SF Bay Area (CA), Investors in San Francisco (CA), Investors in San Mateo (CA)
Investors in BioTech (Series B), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in San Francisco Bay Area (Other Lists)
Photo of Alexander Sinclair-Wilson, Analyst at SV Health Investors
Alexander Sinclair-Wilson
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in London
Investors in Pharmaceuticals (Series B), Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series B), Investors in London (Other Lists), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series B), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series B), Investors in BioTech (Series A), Investors in BioTech (Seed)